Trials / Completed
CompletedNCT01616407
Effects of MDMA and Methylphenidate on Social Cognition
Effects of MDMA (Ecstasy) and Methylphenidate (Ritalin) on Social Cognition
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess and compare the effects of a single dose of 3,4-methylenedioxymethamphetamine (MDMA)and methylphenidate (MPH) on emotional and social cognition in healthy subjects. The investigators hypothesize that MDMA enhances affective perception for positive and impairs perception for negative emotional stimuli compared to placebo or MPH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 3,4-Methylenedioxymethamphetamine | 75 mg per os, single dose |
| DRUG | Methylphenidate | 40 mg per os, single dose |
| DRUG | Placebo | capsules identical to MDMA or methylphenidate but containing no active drug |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2012-12-01
- Completion
- 2013-04-01
- First posted
- 2012-06-11
- Last updated
- 2018-12-11
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01616407. Inclusion in this directory is not an endorsement.